نتایج جستجو برای: leukemia lymphocytic chronic b cell

تعداد نتایج: 2734448  

ژورنال: مجله علمی دانشگاه علوم پزشکی رفسنجان 2008
ماس, پل, پورقیصری, بتول,

  High level of CMV-specific CD4+ and CD8+cells Immune Response and Correlation Between them in B-cell Chronic Lymphocytic Leukemia Patients     B. Pourgheysri [1] , P. Moss [2]     Received: 10/09/07 Sent for Revision: 05/03/08 Received Revised Manuscript: 06/12/08 Accepted: 30/12/08   Background and Objective: Chronic lymphocytic leukemia (CLL) is characterized by a monoclonal proliferation o...

متن کامل
Journal: :avicenna journal of medical biotechnology 0

it has recently been shown that ror1, a member of the receptor tyrosine kinase family, is overexpressed in leukemic b cells of chronic lymphocytic leukemia (cll) and a subset of acute lymphoblastic leukemia (all). in this comparative study the expression profile of ror1 mrna was investigated in iranian patients with cll and acute myelogenous leukemia (aml) and the results were compared with tho...

متن کامل
Journal: :iranian journal of cancer prevention 0
mehrdad payandeh 1. pennathur a, gibson mk, jobe ba, luketich jd. oesophageal carcinoma.lancet. 2013;381(9864):400-12. 2. ferlay j, shin hr, bray f, forman d, mathers c, parkin dm.estimates of worldwide burden of cancer in 2008: globocan 2008. int j cancer. 2010;127:2893–917. 3. lepage c, rachet b, jooste v, faivre j, coleman mp. continuing rapid increase in sophageal adenocarcinoma in england and wales. am j gastroentero.l 2008;103 2694–99. 4. pennathur a, farkas a, krasinskas am. esophagectomy for t1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. ann thorac surg. 2009;87:1048–55. 5. mir mr, rajabpour mv, delarestaghi mm, hadji m, harirchi i, mir p, mir a, lashkari m, zendehdel k. short- and long-term survival of esophageal cancer patients treated at the cancer institute of iran. dig surg. 2013;30(4-6):331-6. 6. harirchi i, kolahdoozan s, hajizadeh s, safari f, sedighi z, nahvijou a, mir mr, mousavi sm, zendehdel k. esophageal cancer in iran; a population-based study regarding adequacy of cancer surgery and overall survival. eur j surg oncol. 2014;40(3):352-7. 7. pennathur a, luketich jd. resection for esophageal cancer:strategies for optimal management. ann thorac surg. 2008;85:751–56. 8. pennathur a, zhang j, chen h, luketich jd. the “best operation”for esophageal cancer? ann thorac surg. 2010;89:2163–67. 9. davies ar, forshaw mj, khan aa, noorani as, patel vm, strauss dc, mason rc. transhiatal esophagectomy in a high volume institution. world j surg oncol. 2008 ;6:88. 10. chang ac, ji h, birkmeyer nj, orringer mb, birkmeyer jd. outcomes after transhiatal and transthoracic esophagectomy for cancer. ann thorac surg. 2008;85(2):424-9. 11. nikbakhsh n, amri p, shakeri a, shakeri a. changes in blood pressure and heart rhythm during transhiatal esophagectomy.caspian j intern med. 2012;3(4):541-5. 12. mallipeddi mk, onaitis mw. the contemporary role of minimally invasive esophagectomy in esophageal cancer. curr oncol rep. 2014;16(3):374. 13. sundaram a, geronimo jc, willer bl, hoshino m, torgersen z, juhasz a, lee th, mittal sk. survival and quality of life after minimally invasive esophagectomy: a single-surgeon experience. surg endosc. 2012;26(1):168-76. 14. herbella fa, patti mg. minimally invasive esophagectomy. world j gastroenterol. 2010;16(30):3811-5. 15. rice tw, blackstone eh, rusch vw. 7th edition of the ajcc cancer staging manual: esophagus and esophagogastric junction.ann surg oncol. 2010;17(7):1721-4 16. d'journo xb, thomas pa. current management of esophageal cancer. j thorac dis. 2014;6 suppl 2:s253-64. 17.hoppo t, jobe ba, hunter jg. minimally invasive esophagectomy: the evolution and technique of minimally invasive surgery for esophageal cancer. world j surg. 2011;35(7):1454-63. 18. dhamija a, dhamija a, hancock j, mccloskey b, kim aw, detterbeck fc, boffa dj. minimally invasive oesophagectomy more expensive than open despite shorter length of stay. eur j cardiothorac surg. 2014;45(5):904-9. 19. galvani ca, gorodner mv, moser f, jacobsen g, chretien c, espat nj, donahue p, horgan s. robotically assisted laparoscopic transhiatal esophagectomy. surg endosc. 2008;22(1):188-95. 20. nguyen nt, hinojosa mw, smith br, chang kj, gray j, hoyt d. minimally invasive esophagectomy: lessons learned from 104 operations. ann surg. 2008;248(6):1081-91. 21. dunn dh, johnson em, morphew ja, dilworth hp, krueger jl, banerji n. robot-assisted transhiatal esophagectomy: a 3-year single-center experience. dis esophagus. 2013;26(2):159-66. 22. maas kw, biere ss, scheepers jj, gisbertz ss, van-der-peet dl, cuesta ma. laparoscopic versus open transhiatal esophagectomy for distal and junction cancer. rev esp enferm dig. 2012;104(4):197-202. 23. rizvi fh, rizvi ss, syed aa, khattak s, khan ar. minimally invasive esophagectomy for esophageal cancer: the first experience from pakistan. int j surg oncol. 2014;2014:864705. 24. tabatabaie sa., hashemi sm,, mohajeri gh,ahmadinejad m, goharian v, kolahdoozan m.,sehhat s, davarpanah ah. incidence of hypotension and type of arrhythmia in transhiatal esophagectomy and evaluation of related factors.iranian journal of surgery. 2009;16(4):59-68. dept. of hematology and medical oncology, kermanshah university of medical sciences, kermanshah, iran masoud sadeghi students research committee, kermanshah university of medical sciences, kermanshah, iran medical biology research center, kermanshah university of medical sciences, kermanshah, iran edris sadeghi students research committee, kermanshah university of medical sciences, kermanshah, iran medical biology research center, kermanshah university of medical sciences, kermanshah, iran

1. dept. of hematology and medical oncology, kermanshah university of medical sciences, kermanshah, iran 2. students research committee, kermanshah university of medical sciences, kermanshah, iran 3. medical biology research center, kermanshah university of medical sciences, kermanshah, iran                                     corresponding author: masoud sadeghi, msc. tel: (+98) 9185960644 ema...

متن کامل
ژورنال: :iranian red crescent medical journal 0
hamideh jafari ghahfarokhi cellular and molecular research center, shahrekord university of medical sciences, shahrekord, ir iran saeede ashoori cellular and molecular research center, shahrekord university of medical sciences, shahrekord, ir iran mohamad taghi akbari department of medical genetics, faculty of medical sciences, tarbiat modares university, tehran, ir iran masoud lotfizadeh department of public health, social health determinants research center, school of health, shahrekord university of medical sciences, shahrekord, ir iran ali karimi medical plant research center, shahrekord university of medical sciences, shahrekord, ir iran hossein teimori cellular and molecular research center, shahrekord university of medical sciences, shahrekord, ir iran; cellular and molecular research center, shahrekord university of medical sciences, shahrekord, ir iran. tel: +98-3813346692, fax: +98-3813330709

background b-cell chronic lymphocytic leukemia (b-cll) is the most common form of leukemia in adults. some reports showed that expression of zap70 gene and chromosomal abnormality are two prognostic factors in management of b-cll objectives in this study, we determined zap70 mrna expression level in the del17p13, del6q21 and del11q13 subgroups of iranian b-cll patients to investigate prognostic...

متن کامل
Journal: :Haematologica 2013
Laia Rosich Ifigènia Saborit-Villarroya Mónica López-Guerra Sílvia Xargay-Torrent Arnau Montraveta Marta Aymerich Neus Villamor Elias Campo Patricia Pérez-Galán Gaël Roué Dolors Colomer

Phosphatidylinositol-3-kinase pathway is constitutively activated in chronic lymphocytic leukemia mainly due to microenvironment signals, including stromal cell interaction and CXCR4 and B-cell receptor activation. Because of the importance of phosphatidylinositol-3-kinase signaling in chronic lymphocytic leukemia, we investigated the activity of the NVP-BKM120, an orally available pan class I ...

متن کامل
Journal: :Revista brasileira de hematologia e hemoterapia 2015
Daniel Mazza Matos Felipe Magalhães Furtado Roberto Passetto Falcão

BACKGROUND Monoclonal B-cell lymphocytosis is classified as 'high-count or clinical' monoclonal B-cell lymphocytosis and 'low-count or population' monoclonal B-cell lymphocytosis. Previously, 167 first-degree relatives pertaining to sporadic (non-familial) chronic lymphocytic leukemia families were studied and the presence of seven monoclonal B-cell lymphocytosis individuals was reported. OBJ...

متن کامل
Journal: :Haematologica 2011
Eleni Arvaniti Stavroula Ntoufa Nikos Papakonstantinou Tasoula Touloumenidou Nikolaos Laoutaris Achilles Anagnostopoulos Klea Lamnissou Federico Caligaris-Cappio Kostas Stamatopoulos Paolo Ghia Marta Muzio Chrysoula Belessi

BACKGROUND Signaling through the B-cell receptor appears to be a major contributor to the pathogenesis of chronic lymphocytic leukemia. Toll-like receptors bridge the innate and adaptive immune responses by acting as co-stimulatory signals for B cells. The available data on the expression of Toll-like receptors in chronic lymphocytic leukemia are limited and derive from small series of patients...

متن کامل
ژورنال: ارمغان دانش 2020
Alipour, Marzieh, Gholamian, Ahmad Reza, Khashei, Khalil, Naeimi, Sirous,

Introduction: Chronic lymphocytic leukemia (CLL) is the most frequent leukemia in adults living in Western countries. with a diverse clinical course that due to life expectancy less than two years between patients finding ,new therapeutic strategies is essential for it. Curcumin as the biologic active of turmeric, has many biological properties such as anti-inflammatory, anti-oxidant, anti-diab...

متن کامل
Journal: :Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 2006
D M Matos E G Rizzatti A B Garcia D A P Gallo R P Falcão

We evaluated the expression of 10 adhesion molecules on peripheral blood tumor cells of 17 patients with chronic lymphocytic leukemia, 17 with mantle-cell lymphoma, and 13 with nodal or splenic marginal B-cell lymphoma, all in the leukemic phase and before the beginning of any therapy. The diagnosis of B-cell non-Hodgkin's lymphomas was based on cytological, histological, immunophenotypic, and ...

متن کامل
Journal: :Annals of clinical and laboratory science 1982
A Castella F R Davey A S Kurec N A Thompson

The presence of terminal deoxynucleotidyl transferase (TdT) has been determined in neoplastic cells from 50 patients with non-hematologic tumors as well as neoplastic cells from 85 patients with hematologic malignancies. The results indicate that TdT is not present in cells from non-hematologic tumors, Hodgkin's lymphoma, B cell lymphoproliferative disorders, peripheral T cell neoplasms, reacti...

متن کامل

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید